| Ticker: | NKTR |
| Current Price: | $37.27 |
| % Daily Change: | 0.05% |
| Volume (1,000s): | 693.95 |
| Average Volume (1,000s): | 1,029.87 |
| Market Cap (M): | $1,069.20 |
| 1/2/2024 Price: | $14.40 |
| Change Since Inception: | 158.82% |
Nektar Therapeutics
455 Mission Bay Boulevard South
San Francisco, CA 94158
United States
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar’s proprietary and proven chemistry platform in the discovery and design of our new drug candidates.